Join this webinar for a compelling presentation from TLD Group Advisor and Senior Consultant Dr. Kent Bottles who discuss American Healthcare in 2021: What Should Providers, Patients, & Citizens Expect?

Missouri’s highest court refused to consider Johnson & Johnson’s appeal of a $2.12 billion damages award to women who blamed their ovarian cancer on asbestos in its baby powder and other talc products.

The U.S. Supreme Court ruled that a 2003 law does not violate constitutional free speech rights by requiring overseas affiliates of American-based nonprofit groups that seek federal funding for HIV/AIDS relief to take a formal stance opposing prostitution and sex trafficking.

The U.S. Supreme Court considered a bid by Donald Trump’s administration to implement rules allowing employers to obtain religious exemptions from an Obamacare requirement that health insurance that they provide to employees covers women’s birth control.

The U.S. Supreme Court ruled in favor of health insurers seeking $12 billion from the federal government under a program set up by the Obamacare law aimed at encouraging them to offer medical coverage to previously uninsured Americans.

The U.S. Supreme Court rejected a bid by the Democratic-controlled House of Representatives and 20 Democratic-led states to fast-track consideration of their appeal seeking a definitive ruling that the Obamacare healthcare law does not violate the U.S. Constitution.

The U.S. Supreme Court turned away a novel case by Arizona seeking to recover billions of dollars that the state has said that members of the Sackler family – owners of Purdue Pharma LP – funneled out of the OxyContin maker before the company filed for bankruptcy in September 2019.

Martin Shkreli will remain in prison until he has completed his sentence as the U.S. Supreme Court refused to overturn his seven-year conviction for securities fraud.

Acorda Therapeutics will terminate approximately 25 percent of headcount as the company initiates a corporate restructuring.

The U.S. Supreme Court agreed to decide whether the federal government must pay insurers $12 billion under an Obamacare program aimed at encouraging them to cover previously uninsured people after the healthcare law was enacted in 2010.